ARINGAGE
LIVE

Serial Number

87900878

Owner

CMG Pharmaceutical Co.,Ltd.

Attorney

Miriam D. Trudell

Filing Date

Apr 30, 2018

Add to watchlist:

No watchlists yet
View on USPTO

ARINGAGE Trademark

Serial Number: 87900878 • Registration: 5970134

ARINGAGE is a trademark filed by CMG Pharmaceutical Co.,Ltd. on April 30, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

CMG Pharmaceutical Co.,Ltd. (6 trademarks)

14, Dosan-daero 66-gil
Gangnam-gu, Seoul , KR

Entity Type: 03

Trademark Details

Filing Date

April 30, 2018

Registration Date

January 28, 2020

Published for Opposition

November 12, 2019

Goods & Services

Pharmaceutical and veterinary preparations for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease; sanitary preparations for medical purposes; biotechnological preparations for medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease; biological preparations for medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease; drugs for medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease; pharmaceuticals for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease; multivitamins preparations; pharmaceutical preparations for diagnosis for medical orveterinary purposes; nutraceutical preparations for therapeutic or medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease; preparations of microorganisms for medical and veterinary use for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease; antibiotics

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 28, 2025 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 14, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 14, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 14, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 14, 2024 REAP
REGISTERED-PRINCIPAL REGISTER
Jan 28, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 12, 2019 NPUB
PUBLISHED FOR OPPOSITION
Nov 12, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 23, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 5, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 26, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 25, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 25, 2019 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Jul 11, 2019 GPRN
PRIORITY ACTION E-MAILED
Jul 11, 2019 GPRA
PRIORITY ACTION WRITTEN
Jul 11, 2019 CPRA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jul 1, 2019 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Mar 26, 2019 PBCR
ELECTRONIC RECORD REVIEW COMPLETE
Mar 12, 2019 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Mar 8, 2019 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 6, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 25, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 25, 2019 CRFA
ASSIGNED TO LIE
Feb 13, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 7, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 21, 2018 GNRN
NON-FINAL ACTION E-MAILED
Aug 21, 2018 GNRT
NON-FINAL ACTION WRITTEN
Aug 21, 2018 CNRT
ASSIGNED TO EXAMINER
Aug 21, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 9, 2018 NWOS
NEW APPLICATION ENTERED
May 3, 2018 NWAP